§1What this business is

Rolls of breathable base material (micropore paper or cotton) run through one adhesive tape machine with unwinding, tensioning, coating, drying, rewinding and slitting stations. The finished tapes hold dressings on skin. Buyers are hospitals, clinics, chemists and medical distributors.

Capacity: 200 boxes of 6 rolls a day, 60,000 boxes a year; 50% in year 1 rising to 70%.

§2Is it right for you?

Who it is for

A medical distributor who wants to make an own-brand product.

Who it is not for

Someone without medical-trade contacts.

Advantages

  • Smaller investment than plaster making
  • One machine line does all steps
  • Used daily in every hospital
  • Low labour need

Drawbacks

  • Bought-in base rolls (the report uses 3M micropore paper) set the cost
  • Drug licence and quality rules apply
  • DSCR under 2 leaves little cushion
  • Big brands dominate

Skills you need

  • Coating machine operation
  • Adhesion and skin-safety testing
  • Drug-licence compliance
  • Hospital and distributor sales

Why difficulty 3/5: One machine line, but drug-licence rules and a thin early margin.

§3Market

Who buys

  • Hospitals and nursing homes
  • Clinics
  • Chemists

How it sells

  • Medical distributors
  • Government tenders and GeM
  • Online pharmacies

Good to know

  • The report says medical and health facilities grew about 12% a year over the four years before it was written.

§4Raw material & machinery

ItemQtyCost
Roll winding machine1₹4,65,000
Slitting tape machine1₹3,50,000
Roll unwinder1₹2,90,000
Roll tensioning machine1₹1,80,000
Drying machine1₹1,45,000
Coating machine1₹65,000

From: PMEGP sample project report — Surgical Adhesive Tape (prepared by Udyami/Samadhan)

  • 3M micropore paper rolls (or cotton base tape)7,500 rolls a year at ₹400 = ₹30 L at full capacity
  • Zinc-oxide based adhesive₹2.50 L a year (lump sum)

From: PMEGP sample project report — Surgical Adhesive Tape (prepared by Udyami/Samadhan)

§5Licences & registration

  1. Udyam
  2. GST
  3. Manufacturing licence from the State Drugs Controller (Drugs and Cosmetics Act / Medical Devices Rules)
  4. Trademark for your brand

We can do this registration for you

§6Schemes & subsidies

PMEGP (the report was made for it), MUDRA up to ₹20 L, CGTMSE for a collateral-free loan, Stand-Up India for SC/ST or women founders.

§7Money

How the investment is worked out: PMEGP sample report: plant & machinery ₹14.95 L, furniture ₹1.00 L, working capital ₹5.55 L = ₹21.50 L. Shed 1,200 sq ft own or rented.

Working capital: Working capital ₹5.55 L (bank ₹5.00 L): 30 days of raw material, 7 days of finished stock.

Year not printed on the report — check current machinery prices.

How to prepare a loan file

§8Export potential

Confirm the HS code in the DGFT ITC(HS) lookup before you export

3005.10Adhesive dressings and other articles having an adhesive layer

Export council / board: Pharmexcil

  • Confirm the 8-digit ITC(HS) line with DGFT or your customs broker.

§9Risks — where people fail

  • Base-roll price or supply
  • Quality complaints (skin rash, weak hold)
  • Thin early margins
  • Tender price pressure

§1030 / 60 / 90-day plan

A general plan that applies to any business. A plan for this business will be added after research.

  1. Days 1–30: Visit a working surgical adhesive tape unit unit, ask 10 buyers about price and quantity, and get quotations from 3 suppliers.
  2. Days 31–60: Udyam and the licences you need (Udyam, GST), a project report (DPR), and the scheme or loan file.
  3. Days 61–90: Space and machines, trial production, and first deliveries to 10 customers.

§11Who to connect with

Not verified yet

Associations, clusters and training institutes — the directory is being built. Connect

§12Watch

There is no episode on this business yet. Shows are coming soon on the Podcast page.

Want to start Surgical Adhesive Tape Unit?

DPR, loan file or registration — ask us on WhatsApp.

Get a DPR / loan file made

Sources

  1. PMEGP sample project report — Surgical Adhesive Tape (prepared by Udyami/Samadhan)

Data review: 6 October 2026. Spotted a mistake? Report it. For information only — not legal or financial advice.